tirzepatide cardiovascular risk UC Irvine researchers project cardiac benefits from weight-loss medication retatrutide clinical trial doses ESC

44 Here, we explored the utility of a natural product, BPC 157, in Clopidogrel-induced gastric injury

Even if you have the slowest progress possible, you could be at -15% of your starting weight in two years from now

Deboever N, Mitchell, KG, Eisenberg MA, Hofstetter WL, Mehran RJ, Rice DC, Rajaram R, Roth JA, Swisher SG, Vaporciyan AA, Walsh GL, Antonoff MB , Sepesi B

SURMOUNT-1: the landmark obesity trial This 72-week, randomized, double-blind, placebo-controlled trial enrolled 2,539 adults with obesity or overweight with at least one weight-related comorbidity

Henry Meds Henry Meds offers several compounded GLP-1 and GIP weight loss medications, which come with personalized care plans

Healthcare providers can assess whether mood changes represent: Medication-related effects potentially requiring dose adjustment or discontinuation (per FDA guidance, Zepbound should be discontinued if suicidal thoughts or behaviors occur) Underlying psychiatric conditions needing specific treatment Physiological factors such as thyroid dysfunction or nutritional deficiencies Situational stressors benefiting from counseling or support services For patients with established mental health care, coordination between prescribers becomes critical